Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.

Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01150-18. doi: 10.1128/AAC.01150-18. Print 2018 Nov.

PMID:
30104278
2.

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.

Yadav R, Rogers KE, Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00078-18. doi: 10.1128/AAC.00078-18. Print 2018 May.

3.

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.

Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02055-17. doi: 10.1128/AAC.02055-17. Print 2018 Apr.

4.

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.

Landersdorfer CB, Yadav R, Rogers KE, Kim TH, Shin BS, Boyce JD, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02053-17. doi: 10.1128/AAC.02053-17. Print 2018 Apr.

5.

Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.

Horibata S, Rogers KE, Sadegh D, Anguish LJ, McElwee JL, Shah P, Thompson PR, Coonrod SA.

BMC Cancer. 2017 May 26;17(1):378. doi: 10.1186/s12885-017-3354-x.

6.

Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.

Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02642-16. doi: 10.1128/AAC.02642-16. Print 2017 May.

7.

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.

Bergen PJ, Bulitta JB, Kirkpatrick CM, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Lipman J, Roberts JA, Landersdorfer CB.

J Antimicrob Chemother. 2016 Sep;71(9):2509-20. doi: 10.1093/jac/dkw153. Epub 2016 May 26.

PMID:
27231278
8.

Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.

Brown LM, Rogers KE, Aroonsakool N, McCammon JA, Insel PA.

J Biol Chem. 2014 Oct 17;289(42):29148-57. doi: 10.1074/jbc.M114.569319. Epub 2014 Sep 2.

9.

Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition.

Brown LM, Rogers KE, McCammon JA, Insel PA.

J Biol Chem. 2014 Mar 21;289(12):8217-30. doi: 10.1074/jbc.M114.548636. Epub 2014 Feb 4.

10.

Variational Implicit-Solvent Modeling of Host-Guest Binding: A Case Study on Cucurbit[7]uril|

Zhou S, Rogers KE, de Oliveira CA, Baron R, Cheng LT, Dzubiella J, Li B, McCammon JA.

J Chem Theory Comput. 2013 Sep 10;9(9):4195-4204. Epub 2013 Aug 1.

11.

Comparing neural-network scoring functions and the state of the art: applications to common library screening.

Durrant JD, Friedman AJ, Rogers KE, McCammon JA.

J Chem Inf Model. 2013 Jul 22;53(7):1726-35. doi: 10.1021/ci400042y. Epub 2013 Jul 11.

12.

On the Role of Dewetting Transitions in Host-Guest Binding Free Energy Calculations.

Rogers KE, Ortiz-Sánchez JM, Baron R, Fajer M, de Oliveira CA, McCammon JA.

J Chem Theory Comput. 2013 Jan 8;9(1):46-53. Epub 2012 Oct 26.

13.

Novel cruzain inhibitors for the treatment of Chagas' disease.

Rogers KE, Keränen H, Durrant JD, Ratnam J, Doak A, Arkin MR, McCammon JA.

Chem Biol Drug Des. 2012 Sep;80(3):398-405. doi: 10.1111/j.1747-0285.2012.01416.x. Epub 2012 Jun 27.

14.

Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases.

Macia L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR.

Immunol Rev. 2012 Jan;245(1):164-76. doi: 10.1111/j.1600-065X.2011.01080.x. Review.

PMID:
22168419
15.

WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.

Whiteside GT, Dwyer JM, Harrison JE, Beyer CE, Cummons T, Manzino L, Mark L, Johnston GH, Strassle BW, Adedoyin A, Lu P, Piesla MJ, Pulicicchio CM, Erve JC, Platt BJ, Hughes ZA, Rogers KE, Deecher DC, Trybulski EJ, Kennedy JD, Zhang P, Leventhal L.

Br J Pharmacol. 2010 Jul;160(5):1105-18. doi: 10.1111/j.1476-5381.2010.00690.x.

16.

Identification of critical amino acid residues for human iNOS functional activity.

Naureckiene S, Kodangattil SR, Kaftan EJ, Jones PG, Kennedy JD, Rogers KE, Chanda PK.

Protein J. 2008 Aug;27(5):309-18. doi: 10.1007/s10930-008-9139-y.

PMID:
18459037
17.

Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia.

Codd EE, Martinez RP, Molino L, Rogers KE, Stone DJ, Tallarida RJ.

Pain. 2008 Feb;134(3):254-62. Epub 2007 May 25.

PMID:
17532139
18.

Direct inhibition of Ih by analgesic loperamide in rat DRG neurons.

Vasilyev DV, Shan Q, Lee Y, Mayer SC, Bowlby MR, Strassle BW, Kaftan EJ, Rogers KE, Dunlop J.

J Neurophysiol. 2007 May;97(5):3713-21. Epub 2007 Mar 28.

19.

Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain.

Leventhal L, Smith V, Hornby G, Andree TH, Brandt MR, Rogers KE.

J Pharmacol Exp Ther. 2007 Mar;320(3):1178-85. Epub 2006 Dec 1.

PMID:
17142646
20.

An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.

Leventhal L, Brandt MR, Cummons TA, Piesla MJ, Rogers KE, Harris HA.

Eur J Pharmacol. 2006 Dec 28;553(1-3):146-8. Epub 2006 Sep 26.

PMID:
17056036
21.

Use of a murine cell line for identification of human nitric oxide synthase inhibitors.

Naureckiene S, Edris W, Ajit SK, Katz AH, Sreekumar K, Rogers KE, Kennedy JD, Jones PG.

J Pharmacol Toxicol Methods. 2007 May-Jun;55(3):303-13. Epub 2006 Aug 17.

PMID:
16990017
22.

High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.

Wang Y, Ramirez F, Krishnamurthy G, Gilbert A, Kadakia N, Xu J, Kalgaonkar G, Ramarao MK, Edris W, Rogers KE, Jones PG.

J Biomol Screen. 2006 Aug;11(5):519-27. Epub 2006 Jun 7.

PMID:
16760367
23.

A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening.

Wang Y, Xu J, Uveges A, Ramarao MK, Rogers KE, Jones PG.

Anal Biochem. 2006 Jul 1;354(1):35-42. Epub 2006 May 2.

PMID:
16707086
24.

Cloning, localization, and functional expression of sodium channel beta1A subunits.

Kazen-Gillespie KA, Ragsdale DS, D'Andrea MR, Mattei LN, Rogers KE, Isom LL.

J Biol Chem. 2000 Jan 14;275(2):1079-88.

25.

Gene expression profiles of laser-captured adjacent neuronal subtypes.

Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, Erlander MG.

Nat Med. 1999 Jan;5(1):117-22. No abstract available. Erratum in: Nat Med 1999 Mar;5(3):355.

PMID:
9883850
26.

Identification of a neuronal calmodulin-binding peptide, CAP-19, containing an IQ motif.

Smith ML, Johanson RA, Rogers KE, Coleman PD, Slemmon JR.

Brain Res Mol Brain Res. 1998 Nov 12;62(1):12-24.

PMID:
9795107
27.

Metabolite and matrix interference in phenytoin immunoassays.

Rainey PM, Rogers KE, Roberts WL.

Clin Chem. 1996 Oct;42(10):1645-53.

28.

The human brain homeogene, DLX-2: cDNA sequence and alignment with the murine homologue.

Selski DJ, Thomas NE, Coleman PD, Rogers KE.

Gene. 1993 Oct 15;132(2):301-3.

PMID:
7901126
29.

The neuropil and GAP-43/B-50 in normally aging and Alzheimer's disease human brain.

Coleman PD, Rogers KE, Flood DG.

Prog Brain Res. 1991;89:263-9. Review. No abstract available.

PMID:
1839068
30.

Neuronal plasticity in normal aging and deficient plasticity in Alzheimer's disease: a proposed intercellular signal cascade.

Coleman PD, Rogers KE, Flood DG.

Prog Brain Res. 1990;86:75-87. Review. No abstract available.

PMID:
2150889
31.

Molecular cloning and sequencing of a cDNA for olfactory marker protein.

Rogers KE, Dasgupta P, Gubler U, Grillo M, Khew-Goodall YS, Margolis FL.

Proc Natl Acad Sci U S A. 1987 Mar;84(6):1704-8.

32.

Olfactory neuron-specific protein is translated from a large poly(A)+ mRNA.

Rogers KE, Grillo M, Sydor W, Poonian M, Margolis FL.

Proc Natl Acad Sci U S A. 1985 Aug;82(15):5218-22.

33.

Novel mode of cytotoxicity obtained by coupling inactive anthracycline to a polymer.

Rogers KE, Tökés ZA.

Biochem Pharmacol. 1984 Feb 15;33(4):605-8.

PMID:
6422950
34.
35.

Endoscopic cytology and biopsy in the diagnosis of gastroesophageal malignancy.

Gupta RK, Rogers KE.

Acta Cytol. 1983 Jan-Feb;27(1):17-22.

PMID:
6573825
36.

Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.

Tokes ZA, Rogers KE, Rembaum A.

Proc Natl Acad Sci U S A. 1982 Mar;79(6):2026-30.

37.

A unique case of aorticoduodenal fistula following carcinoma of cervix.

Gupta RK, Rogers KE.

Am J Obstet Gynecol. 1978 May 1;131(1):110-3. No abstract available.

PMID:
306199
38.

Payment for chiropractic services.

Rogers KE.

Can Med Assoc J. 1970 Sep 26;103(6):651. No abstract available.

39.

Primary carcinoma of the third part of the duodenum.

ROGERS KE, GOLIGHER JC, WILLIAMS ER.

Br J Surg. 1952 Jul;40(159):1-5. No abstract available.

PMID:
14944786
40.

Effect of pancreatectomy on phospholipid synthesis in the dog.

BARKER WF, ROGERS KE, MOORE FD.

AMA Arch Surg. 1950 Dec;61(6):1151-62. No abstract available.

PMID:
14777245
41.

A papillary cystadenoma of the common hepatic duct.

ROGERS KE.

Can Med Assoc J. 1946 Dec;55(6):597-9. No abstract available.

Supplemental Content

Loading ...
Support Center